This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Osaka University. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Antti Markus Siltanen: Innovator in Stem Cell Research
Introduction
Antti Markus Siltanen is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of stem cell research, particularly in the development of methods for preparing cardiomyocyte populations. His work aims to enhance the clinical applicability and safety of stem cell-derived therapies.
Latest Patents
Siltanen holds a patent for a "Method for preparing pluripotent stem cell-derived cardiomyocyte population." This innovative method provides a clinically applicable, safe, and less damaged cardiomyocyte population through a brief and simple procedure. The process involves induced differentiation of pluripotent stem cells into cardiomyocytes, which is crucial for advancing cardiac therapies.
Career Highlights
Antti Markus Siltanen is affiliated with Osaka University, where he conducts his research. His work has garnered attention for its potential to improve treatment options for heart diseases. With 1 patent to his name, Siltanen is recognized for his contributions to the scientific community.
Collaborations
Siltanen has collaborated with notable colleagues, including Yukiko Ochi and Kiyotoshi Sekiguchi. These partnerships have furthered research efforts in the field of stem cell technology and its applications in medicine.
Conclusion
Antti Markus Siltanen is a key figure in stem cell research, with a focus on developing safe and effective cardiomyocyte populations. His innovative methods and collaborations continue to pave the way for advancements in cardiac therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile